Cargando…
Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD)
INTRODUCTION: The risk reduction for Alzheimer's disease (rrAD) trial was a multisite clinical trial to assess exercise and intensive vascular pharmacological treatment on cognitive function in community‐dwelling older adults at increased risk for Alzheimer's disease. METHODS: Eligibility,...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576444/ https://www.ncbi.nlm.nih.gov/pubmed/37841653 http://dx.doi.org/10.1002/trc2.12422 |
_version_ | 1785121123184148480 |
---|---|
author | Szabo‐Reed, Amanda N. Hall, Tristyn Vidoni, Eric D. Van Sciver, Angela Sewell, Monica Burns, Jeffrey M. Cullum, C. Munro Gahan, William P. Hynan, Linda S. Kerwin, Diana R. Rossetti, Heidi Stowe, Ann M. Vongpatanasin, Wanpen Zhu, David C. Zhang, Rong Keller, Jeffrey N. Binder, Ellen F. |
author_facet | Szabo‐Reed, Amanda N. Hall, Tristyn Vidoni, Eric D. Van Sciver, Angela Sewell, Monica Burns, Jeffrey M. Cullum, C. Munro Gahan, William P. Hynan, Linda S. Kerwin, Diana R. Rossetti, Heidi Stowe, Ann M. Vongpatanasin, Wanpen Zhu, David C. Zhang, Rong Keller, Jeffrey N. Binder, Ellen F. |
author_sort | Szabo‐Reed, Amanda N. |
collection | PubMed |
description | INTRODUCTION: The risk reduction for Alzheimer's disease (rrAD) trial was a multisite clinical trial to assess exercise and intensive vascular pharmacological treatment on cognitive function in community‐dwelling older adults at increased risk for Alzheimer's disease. METHODS: Eligibility, consent, and randomization rates across different referral sources were compared. Informal interviews conducted with each site's project team were conducted upon study completion. RESULTS: Initially, 3290 individuals were screened, of whom 28% were eligible to consent, 805 consented to participate (87.2% of those eligible), and 513 (36.3% of those consented) were randomized. Emails sent from study site listservs/databases yielded the highest amount (20.9%) of screened individuals. Professional referrals from physicians yielded the greatest percentage of consented individuals (57.1%). Referrals from non‐professional contacts (ie, friends, family; 75%) and mail/phone contact from a site (73.8%) had the highest yield of randomization. DISCUSSION: Professional referrals or email from listservs/registries were most effective for enrolling participants. The greatest yield of eligible/randomized participants came from non‐professional and mail/phone contacts. Future trials should consider special efforts targeting these recruitment approaches. HIGHLIGHTS: Clinical trial recruitment is commonly cited as a significant barrier to advancing our understanding of cognitive health interventions. The most cited referral source was email, followed by interviews/editorials on the radio, television, local newspapers, newsletters, or magazine articles. The referral method that brought in the largest number of contacts was email but did not result in the greatest yield of consents or eligible participants. The sources that yielded the greatest likelihood of consent were professional referrals (ie, physician), social media, and mail/phone contact from study site. The greatest yield of eligible/randomized participants came from non‐professional contacts and mail/phone contact from a site. Findings suggest that sites may need to focus on more selective referral sources, such as using contact mailing and phone lists, rather than more widely viewed recruitment sources, such as social media or TV/radio advertisements. |
format | Online Article Text |
id | pubmed-10576444 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105764442023-10-15 Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD) Szabo‐Reed, Amanda N. Hall, Tristyn Vidoni, Eric D. Van Sciver, Angela Sewell, Monica Burns, Jeffrey M. Cullum, C. Munro Gahan, William P. Hynan, Linda S. Kerwin, Diana R. Rossetti, Heidi Stowe, Ann M. Vongpatanasin, Wanpen Zhu, David C. Zhang, Rong Keller, Jeffrey N. Binder, Ellen F. Alzheimers Dement (N Y) Research Articles INTRODUCTION: The risk reduction for Alzheimer's disease (rrAD) trial was a multisite clinical trial to assess exercise and intensive vascular pharmacological treatment on cognitive function in community‐dwelling older adults at increased risk for Alzheimer's disease. METHODS: Eligibility, consent, and randomization rates across different referral sources were compared. Informal interviews conducted with each site's project team were conducted upon study completion. RESULTS: Initially, 3290 individuals were screened, of whom 28% were eligible to consent, 805 consented to participate (87.2% of those eligible), and 513 (36.3% of those consented) were randomized. Emails sent from study site listservs/databases yielded the highest amount (20.9%) of screened individuals. Professional referrals from physicians yielded the greatest percentage of consented individuals (57.1%). Referrals from non‐professional contacts (ie, friends, family; 75%) and mail/phone contact from a site (73.8%) had the highest yield of randomization. DISCUSSION: Professional referrals or email from listservs/registries were most effective for enrolling participants. The greatest yield of eligible/randomized participants came from non‐professional and mail/phone contacts. Future trials should consider special efforts targeting these recruitment approaches. HIGHLIGHTS: Clinical trial recruitment is commonly cited as a significant barrier to advancing our understanding of cognitive health interventions. The most cited referral source was email, followed by interviews/editorials on the radio, television, local newspapers, newsletters, or magazine articles. The referral method that brought in the largest number of contacts was email but did not result in the greatest yield of consents or eligible participants. The sources that yielded the greatest likelihood of consent were professional referrals (ie, physician), social media, and mail/phone contact from study site. The greatest yield of eligible/randomized participants came from non‐professional contacts and mail/phone contact from a site. Findings suggest that sites may need to focus on more selective referral sources, such as using contact mailing and phone lists, rather than more widely viewed recruitment sources, such as social media or TV/radio advertisements. John Wiley and Sons Inc. 2023-10-14 /pmc/articles/PMC10576444/ /pubmed/37841653 http://dx.doi.org/10.1002/trc2.12422 Text en © 2023 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Szabo‐Reed, Amanda N. Hall, Tristyn Vidoni, Eric D. Van Sciver, Angela Sewell, Monica Burns, Jeffrey M. Cullum, C. Munro Gahan, William P. Hynan, Linda S. Kerwin, Diana R. Rossetti, Heidi Stowe, Ann M. Vongpatanasin, Wanpen Zhu, David C. Zhang, Rong Keller, Jeffrey N. Binder, Ellen F. Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD) |
title | Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD) |
title_full | Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD) |
title_fullStr | Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD) |
title_full_unstemmed | Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD) |
title_short | Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD) |
title_sort | recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for alzheimer's disease (rrad) |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576444/ https://www.ncbi.nlm.nih.gov/pubmed/37841653 http://dx.doi.org/10.1002/trc2.12422 |
work_keys_str_mv | AT szaboreedamandan recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad AT halltristyn recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad AT vidoniericd recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad AT vansciverangela recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad AT sewellmonica recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad AT burnsjeffreym recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad AT cullumcmunro recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad AT gahanwilliamp recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad AT hynanlindas recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad AT kerwindianar recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad AT rossettiheidi recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad AT stoweannm recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad AT vongpatanasinwanpen recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad AT zhudavidc recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad AT zhangrong recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad AT kellerjeffreyn recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad AT binderellenf recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad |